Mineralys Therapeutics, Inc.
MLYS
$14.25
$0.755.56%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -24.82% | -15.27% | -8.11% | 43.12% | -6.78% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 73.50% | -40.04% | -16.57% | -34.16% | 7.94% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -23.30% | -15.81% | -8.31% | 39.23% | -6.13% |
|
|||||
Total Current Assets | -23.30% | -15.81% | -8.31% | 39.23% | -6.13% |
Net Property, Plant & Equipment | -23.19% | 64.29% | -17.65% | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 10.40% | 0.67% | 18.47% | 643.14% | 0.00% |
Total Assets | -23.24% | -15.77% | -8.28% | 38.00% | -9.34% |
|
|||||
Total Accounts Payable | -84.58% | 81.96% | -59.94% | 608.99% | -89.22% |
Total Accrued Expenses | -49.79% | 5.71% | 78.61% | 51.23% | 23.98% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -53.24% | 10.30% | 47.87% | 83.21% | -22.60% |
|
|||||
Total Current Liabilities | -53.24% | 10.30% | 47.87% | 83.21% | -22.60% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -53.24% | 10.30% | 47.87% | 83.21% | -22.60% |
|
|||||
Common Stock & APIC | 0.67% | 0.65% | 0.63% | 32.36% | 0.42% |
Retained Earnings | -19.30% | -28.57% | -26.25% | -25.27% | -24.31% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -19.28% | -18.33% | -11.57% | 36.03% | -8.66% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -19.28% | -18.33% | -11.57% | 36.03% | -8.66% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -19.28% | -18.33% | -11.57% | 36.03% | -8.66% |
|